VYNE CEO David Domzalski Withholds 79,391 Shares for Taxes

What Happened

• David Domzalski, President & CEO and Director of VYNE Therapeutics (VYNE), had 79,391 shares withheld by the company to satisfy tax withholding in connection with the vesting of restricted stock units (RSUs). The shares were valued at $0.90 each, representing approximately $71,261. This was a tax-withholding disposal (not an open-market sale or a purchase).

Key Details

• Transaction date: 2026-07-23; filing date (Form 4): 2026-07-24 (timely filed).
• Shares withheld: 79,391 at $0.90 per share; total value ≈ $71,261.
• Transaction code: F (tax withholding/cashless share withholding on vested RSUs).
• Footnote: F1 — shares withheld by the issuer to satisfy tax withholding requirements related to RSU vesting.
• Shares owned after transaction: not specified in the provided filing excerpt.

Context

• This was a routine tax-withholding event tied to RSU vesting (a common cashless method the company uses to cover taxes). It is not an open-market sale and generally does not signal a change in the insider’s view of the company.
• For retail investors, purchases and open-market sales can be more informative about insider sentiment than withholding transactions like this one.